Brod M, McLeod L, Markova D, Gianettoni J, Mourya S, Lin Z, Shu A, Smith A. Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES). J Patient Rep Outcomes. 2021 Aug 10;5(1):70. doi: 10.1186/s41687-021-00320-2
McLeod L, Sikirica MV, Qin S, Joshi AV, Sweeney CT, Blum SI. Psychometric evaluation of the nausea and vomiting questionnaire in patients with type 2 diabetes mellitus receiving a glucagon-like peptide-1 receptor agonist. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A175.
McLeod L, Sikirica MV, Davenport E, Sweeney CT, Joshi AV. The impact of GLP-1 induced nausea and vomiting on work productivity and health-related quality of life in patients with T2DM. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A172.
Traina SB, McQuarrie K, Barrett A, DiBenedetti D, McLeod L. Content validity of the current health satisfaction questionnaire (CHES-Q) among people living with type 2 diabetes mellitus and comorbid chronic kidney disease (CKD). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Webb S, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczylski W, De Block C, Portocarrero-Ortiz L, Gadelha MR. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease. Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013
Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X. Psychometric evaluation of the Cushing's Quality-of-Life Questionnaire. Patient. 2013 Apr 1;Advance Online.
Badia X, Forsythe A, Nelson LM, Coles TM, McLeod LD, Webb SM. Improvements in health-related quality of life in acromegaly with pasireotide LAR and octreotide LAR: results from a large, randomized, double-blind phase III trial. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A505.
Badia X, Roset M, Forsythe A, Coles TM, McLeod LD, Nelson LM. Clinical and patient-reported outcomes associated to pasireotide in patients with Cushing's disease. Poster presented at the 15th Annual Congress of the European Neuroendocrine Association; September 2012.
McLeod LD, Pulgar S, Nelson LM, Maldonado M, Gilligan T, Zhang Y. Psychometric evaluation of the Cushing's quality of life questionnaire (CushingQOL). Poster presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.
Lee LJ, Fahrbach JL, Nelson LM, McLeod LD, Martin SA, Sun P, Weinstock RS. Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the DURABLE trial. Diabetes Res Clin Pract. 2010 Aug 1;89(2):157-66.
Lee J, McLeod LD, Nelson LM, Hill C, Sweeney CT, Sun P. Initiation of insulin therapy improves self-reported diabetes symptoms in patients (Pts) with type 2 diabetes (T2D) on oral agents. Poster presented at the 69th Scientific Sessions of the American Diabetes Association; June 2009.
Lee LJ, Nelson LM, McLeod LD, Hill CD, Sweeney CT. Effects of insulin therapy on the Diabetes Symptom Checklist-Revised (DSC-R): data from a large insulin clinical trial. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 21, 2009. [abstract] Value Health. 12(3):A105.